Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Influenza B virus antigen
- Molecular classification
- Viral protein, Hemagglutinin (HA), Neuraminidase (NA), Envelope protein
01
Overview
Influenza B virus antigens, primarily hemagglutinin (HA) and neuraminidase (NA), are viral proteins recognized by the immune system. They mediate viral entry and release and are the main targets for neutralizing antibodies and antiviral drugs. HA is subject to antigenic drift, leading to the emergence of new strains and the need for annual vaccination. NA is the target for neuraminidase inhibitors. Other envelope proteins like NB/BM2 also play roles.
02
Mechanism of action
Neuraminidase inhibitors block the activity of neuraminidase, preventing the release of new virions from infected cells.
03
Biological functions
Mediate cell entryMediate viral releaseElicit immune response
04
Disease associations
Infection
05
Interacting drugs
Neuraminidase inhibitors (e.g., Oseltamivir, Zanamivir)
Beyond the preview
Go deeper on Influenza B virus antigen.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Influenza B virus antigen.